Heart disease costs are predicted to triple in the next 20 years in the U.S., according to predictions from the American Heart Association (AHA).

A new study counters the claim that statins (cholesterol-lowering drugs) only work for individuals with a certain protein.

According to new research from Johns Hopkins University in Baltimore, about a quarter of African-Americans have a gene that helps protect them against heart disease.

Costs associated with treating heart disease and heart conditions increased more than 200 percent in Canada from 1996 to 2006, and are expected to triple in the U.S. by 2030.

Curbing salt intake in teens could reduce the number of young adults with high blood pressure, while imposing statutory limits of salt content in foods appears most effective way to cut intake.

Statin drugs such as Crestor and Lipitor, which work to lower LDL, or "bad" cholesterol and guard against heart disease and stroke, may actually pose more threat than benefit to stroke patients.